 | • レポートコード：GIR-105X12828 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、腫瘍/がん治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腫瘍/がん治療薬の種類別市場規模（代謝拮抗剤、アルカロイド薬、ホルモン、標的薬、プラチナ系薬、その他）、用途別市場規模（血液がん、乳がん、胃腸がん、前立腺がん、呼吸器/肺がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・腫瘍/がん治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche、HENGRUI、AstraZeneca、QILU、Sanofi、HANSOH、LUYE、Novartis、GuiZhou YiBai、Lunan、Eli Lilly and Company ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：代謝拮抗剤、アルカロイド薬、ホルモン、標的薬、プラチナ系薬、その他 ・用途別分析2016年-2026年：血液がん、乳がん、胃腸がん、前立腺がん、呼吸器/肺がん、その他 ・腫瘍/がん治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腫瘍/がん治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腫瘍/がん治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腫瘍/がん治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腫瘍/がん治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oncology/Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oncology/Cancer Drugs size is estimated to be xx million in 2021 from USD 96320 million in 2020, with a change of XX% between 2020 and 2021. The global Oncology/Cancer Drugs market size is expected to grow at a CAGR of 4.1% for the next five years.
Market segmentation
Oncology/Cancer Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Antimetabolite
Alkaloid drugs
Hormone
Targeted drug
Platinum-based drugs
Other
Market segment by Application can be divided into
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other
The key market players for global Oncology/Cancer Drugs market are listed below:
Roche
HENGRUI
AstraZeneca
QILU
Sanofi
HANSOH
LUYE
Novartis
GuiZhou YiBai
Lunan
Eli Lilly and Company
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Oncology/Cancer Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oncology/Cancer Drugs, with price, sales, revenue and global market share of Oncology/Cancer Drugs from 2019 to 2021.
Chapter 3, the Oncology/Cancer Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology/Cancer Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Oncology/Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Oncology/Cancer Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Oncology/Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oncology/Cancer Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Antimetabolite
1.2.3 Alkaloid drugs
1.2.4 Hormone
1.2.5 Targeted drug
1.2.6 Platinum-based drugs
1.2.7 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Oncology/Cancer Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Other
1.4 Global Oncology/Cancer Drugs Market Size & Forecast
1.4.1 Global Oncology/Cancer Drugs Sales in Value (2016-2026))
1.4.2 Global Oncology/Cancer Drugs Sales in Volume (2016-2026)
1.4.3 Global Oncology/Cancer Drugs Price by Type (2016-2026) & (USD/MT)
1.5 Global Oncology/Cancer Drugs Production Capacity Analysis
1.5.1 Global Oncology/Cancer Drugs Total Production Capacity (2016-2026)
1.5.2 Global Oncology/Cancer Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology/Cancer Drugs Market Drivers
1.6.2 Oncology/Cancer Drugs Market Restraints
1.6.3 Oncology/Cancer Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Oncology/Cancer Drugs Product and Services
2.1.4 Roche Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 HENGRUI
2.2.1 HENGRUI Details
2.2.2 HENGRUI Major Business
2.2.3 HENGRUI Oncology/Cancer Drugs Product and Services
2.2.4 HENGRUI Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Oncology/Cancer Drugs Product and Services
2.3.4 AstraZeneca Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 QILU
2.4.1 QILU Details
2.4.2 QILU Major Business
2.4.3 QILU Oncology/Cancer Drugs Product and Services
2.4.4 QILU Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Oncology/Cancer Drugs Product and Services
2.5.4 Sanofi Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 HANSOH
2.6.1 HANSOH Details
2.6.2 HANSOH Major Business
2.6.3 HANSOH Oncology/Cancer Drugs Product and Services
2.6.4 HANSOH Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 LUYE
2.7.1 LUYE Details
2.7.2 LUYE Major Business
2.7.3 LUYE Oncology/Cancer Drugs Product and Services
2.7.4 LUYE Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Oncology/Cancer Drugs Product and Services
2.8.4 Novartis Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 GuiZhou YiBai
2.9.1 GuiZhou YiBai Details
2.9.2 GuiZhou YiBai Major Business
2.9.3 GuiZhou YiBai Oncology/Cancer Drugs Product and Services
2.9.4 GuiZhou YiBai Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Lunan
2.10.1 Lunan Details
2.10.2 Lunan Major Business
2.10.3 Lunan Oncology/Cancer Drugs Product and Services
2.10.4 Lunan Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Eli Lilly and Company
2.11.1 Eli Lilly and Company Details
2.11.2 Eli Lilly and Company Major Business
2.11.3 Eli Lilly and Company Oncology/Cancer Drugs Product and Services
2.11.4 Eli Lilly and Company Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Oncology/Cancer Drugs Sales by Manufacturer
3.1 Global Oncology/Cancer Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Oncology/Cancer Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Oncology/Cancer Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Oncology/Cancer Drugs Manufacturer Market Share
3.4.2 Top 6 Oncology/Cancer Drugs Manufacturer Market Share
3.5 Global Oncology/Cancer Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Oncology/Cancer Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oncology/Cancer Drugs Market Size by Region
4.1.1 Global Oncology/Cancer Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Oncology/Cancer Drugs Revenue by Region (2016-2026)
4.2 North America Oncology/Cancer Drugs Revenue (2016-2026)
4.3 Europe Oncology/Cancer Drugs Revenue (2016-2026)
4.4 Asia-Pacific Oncology/Cancer Drugs Revenue (2016-2026)
4.5 South America Oncology/Cancer Drugs Revenue (2016-2026)
4.6 Middle East and Africa Oncology/Cancer Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Oncology/Cancer Drugs Sales in Volume by Type (2016-2026)
5.2 Global Oncology/Cancer Drugs Revenue by Type (2016-2026)
5.3 Global Oncology/Cancer Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Oncology/Cancer Drugs Sales in Volume by Application (2016-2026)
6.2 Global Oncology/Cancer Drugs Revenue by Application (2016-2026)
6.3 Global Oncology/Cancer Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Oncology/Cancer Drugs Sales by Type (2016-2026)
7.2 North America Oncology/Cancer Drugs Sales by Application (2016-2026)
7.3 North America Oncology/Cancer Drugs Market Size by Country
7.3.1 North America Oncology/Cancer Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Oncology/Cancer Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Oncology/Cancer Drugs Sales by Type (2016-2026)
8.2 Europe Oncology/Cancer Drugs Sales by Application (2016-2026)
8.3 Europe Oncology/Cancer Drugs Market Size by Country
8.3.1 Europe Oncology/Cancer Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Oncology/Cancer Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Oncology/Cancer Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Oncology/Cancer Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Oncology/Cancer Drugs Market Size by Region
9.3.1 Asia-Pacific Oncology/Cancer Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Oncology/Cancer Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Oncology/Cancer Drugs Sales by Type (2016-2026)
10.2 South America Oncology/Cancer Drugs Sales by Application (2016-2026)
10.3 South America Oncology/Cancer Drugs Market Size by Country
10.3.1 South America Oncology/Cancer Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Oncology/Cancer Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oncology/Cancer Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Oncology/Cancer Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Oncology/Cancer Drugs Market Size by Country
11.3.1 Middle East & Africa Oncology/Cancer Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Oncology/Cancer Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Oncology/Cancer Drugs Typical Distributors
12.3 Oncology/Cancer Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Oncology/Cancer Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Oncology/Cancer Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Oncology/Cancer Drugs Product and Services
Table 6. Roche Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. HENGRUI Basic Information, Manufacturing Base and Competitors
Table 8. HENGRUI Major Business
Table 9. HENGRUI Oncology/Cancer Drugs Product and Services
Table 10. HENGRUI Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 12. AstraZeneca Major Business
Table 13. AstraZeneca Oncology/Cancer Drugs Product and Services
Table 14. AstraZeneca Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. QILU Basic Information, Manufacturing Base and Competitors
Table 16. QILU Major Business
Table 17. QILU Oncology/Cancer Drugs Product and Services
Table 18. QILU Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Oncology/Cancer Drugs Product and Services
Table 22. Sanofi Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. HANSOH Basic Information, Manufacturing Base and Competitors
Table 24. HANSOH Major Business
Table 25. HANSOH Oncology/Cancer Drugs Product and Services
Table 26. HANSOH Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. LUYE Basic Information, Manufacturing Base and Competitors
Table 28. LUYE Major Business
Table 29. LUYE Oncology/Cancer Drugs Product and Services
Table 30. LUYE Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Major Business
Table 33. Novartis Oncology/Cancer Drugs Product and Services
Table 34. Novartis Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. GuiZhou YiBai Basic Information, Manufacturing Base and Competitors
Table 36. GuiZhou YiBai Major Business
Table 37. GuiZhou YiBai Oncology/Cancer Drugs Product and Services
Table 38. GuiZhou YiBai Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Lunan Basic Information, Manufacturing Base and Competitors
Table 40. Lunan Major Business
Table 41. Lunan Oncology/Cancer Drugs Product and Services
Table 42. Lunan Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly and Company Major Business
Table 45. Eli Lilly and Company Oncology/Cancer Drugs Product and Services
Table 46. Eli Lilly and Company Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Oncology/Cancer Drugs Sales by Manufacturer (2019-2021e) & (K MT)
Table 48. Global Oncology/Cancer Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Oncology/Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Oncology/Cancer Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 51. Head Office and Oncology/Cancer Drugs Production Site of Key Manufacturer
Table 52. Oncology/Cancer Drugs New Entrant and Capacity Expansion Plans
Table 53. Oncology/Cancer Drugs Mergers & Acquisitions in the Past Five Years
Table 54. Global Oncology/Cancer Drugs Sales by Region (2016-2021e) & (K MT)
Table 55. Global Oncology/Cancer Drugs Sales by Region (2021-2026) & (K MT)
Table 56. Global Oncology/Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 57. Global Oncology/Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 58. Global Oncology/Cancer Drugs Sales by Type (2016-2021e) & (K MT)
Table 59. Global Oncology/Cancer Drugs Sales by Type (2021-2026) & (K MT)
Table 60. Global Oncology/Cancer Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 61. Global Oncology/Cancer Drugs Revenue by Type (2021-2026) & (USD Million)
Table 62. Global Oncology/Cancer Drugs Price by Type (2016-2021e) & (USD/MT)
Table 63. Global Oncology/Cancer Drugs Price by Type (2021-2026) & (USD/MT)
Table 64. Global Oncology/Cancer Drugs Sales by Application (2016-2021e) & (K MT)
Table 65. Global Oncology/Cancer Drugs Sales by Application (2021-2026) & (K MT)
Table 66. Global Oncology/Cancer Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 67. Global Oncology/Cancer Drugs Revenue by Application (2021-2026) & (USD Million)
Table 68. Global Oncology/Cancer Drugs Price by Application (2016-2021e) & (USD/MT)
Table 69. Global Oncology/Cancer Drugs Price by Application (2021-2026) & (USD/MT)
Table 70. North America Oncology/Cancer Drugs Sales by Country (2016-2021e) & (K MT)
Table 71. North America Oncology/Cancer Drugs Sales by Country (2021-2026) & (K MT)
Table 72. North America Oncology/Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 73. North America Oncology/Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 74. North America Oncology/Cancer Drugs Sales by Type (2016-2021e) & (K MT)
Table 75. North America Oncology/Cancer Drugs Sales by Type (2021-2026) & (K MT)
Table 76. North America Oncology/Cancer Drugs Sales by Application (2016-2021e) & (K MT)
Table 77. North America Oncology/Cancer Drugs Sales by Application (2021-2026) & (K MT)
Table 78. Europe Oncology/Cancer Drugs Sales by Country (2016-2021e) & (K MT)
Table 79. Europe Oncology/Cancer Drugs Sales by Country (2021-2026) & (K MT)
Table 80. Europe Oncology/Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 81. Europe Oncology/Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 82. Europe Oncology/Cancer Drugs Sales by Type (2016-2021e) & (K MT)
Table 83. Europe Oncology/Cancer Drugs Sales by Type (2021-2026) & (K MT)
Table 84. Europe Oncology/Cancer Drugs Sales by Application (2016-2021e) & (K MT)
Table 85. Europe Oncology/Cancer Drugs Sales by Application (2021-2026) & (K MT)
Table 86. Asia-Pacific Oncology/Cancer Drugs Sales by Region (2016-2021e) & (K MT)
Table 87. Asia-Pacific Oncology/Cancer Drugs Sales by Region (2021-2026) & (K MT)
Table 88. Asia-Pacific Oncology/Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 89. Asia-Pacific Oncology/Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Oncology/Cancer Drugs Sales by Type (2016-2021e) & (K MT)
Table 91. Asia-Pacific Oncology/Cancer Drugs Sales by Type (2021-2026) & (K MT)
Table 92. Asia-Pacific Oncology/Cancer Drugs Sales by Application (2016-2021e) & (K MT)
Table 93. Asia-Pacific Oncology/Cancer Drugs Sales by Application (2021-2026) & (K MT)
Table 94. South America Oncology/Cancer Drugs Sales by Country (2016-2021e) & (K MT)
Table 95. South America Oncology/Cancer Drugs Sales by Country (2021-2026) & (K MT)
Table 96. South America Oncology/Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 97. South America Oncology/Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 98. South America Oncology/Cancer Drugs Sales by Type (2016-2021e) & (K MT)
Table 99. South America Oncology/Cancer Drugs Sales by Type (2021-2026) & (K MT)
Table 100. South America Oncology/Cancer Drugs Sales by Application (2016-2021e) & (K MT)
Table 101. South America Oncology/Cancer Drugs Sales by Application (2021-2026) & (K MT)
Table 102. Middle East & Africa Oncology/Cancer Drugs Sales by Country (2016-2021e) & (K MT)
Table 103. Middle East & Africa Oncology/Cancer Drugs Sales by Country (2021-2026) & (K MT)
Table 104. Middle East & Africa Oncology/Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 105. Middle East & Africa Oncology/Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 106. Middle East & Africa Oncology/Cancer Drugs Sales by Type (2016-2021e) & (K MT)
Table 107. Middle East & Africa Oncology/Cancer Drugs Sales by Type (2021-2026) & (K MT)
Table 108. Middle East & Africa Oncology/Cancer Drugs Sales by Application (2016-2021e) & (K MT)
Table 109. Middle East & Africa Oncology/Cancer Drugs Sales by Application (2021-2026) & (K MT)
Table 110. Direct Channel Pros & Cons
Table 111. Indirect Channel Pros & Cons
Table 112. Oncology/Cancer Drugs Typical Distributors
Table 113. Oncology/Cancer Drugs Typical Customers
List of Figures
Figure 1. Oncology/Cancer Drugs Picture
Figure 2. Global Oncology/Cancer Drugs Sales Market Share by Type in 2020
Figure 3. Antimetabolite
Figure 4. Alkaloid drugs
Figure 5. Hormone
Figure 6. Targeted drug
Figure 7. Platinum-based drugs
Figure 8. Other
Figure 9. Global Oncology/Cancer Drugs Sales Market Share by Application in 2020
Figure 10. Blood Cancer
Figure 11. Breast Cancer
Figure 12. Gastrointestinal Cancer
Figure 13. Prostate Cancer
Figure 14. Respiratory/Lung Cancer
Figure 15. Other
Figure 16. Global Oncology/Cancer Drugs Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 17. Global Oncology/Cancer Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 18. Global Oncology/Cancer Drugs Sales (2016-2026) & (K MT)
Figure 19. Global Oncology/Cancer Drugs Price by Type (2016-2026) & (USD/MT)
Figure 20. Global Oncology/Cancer Drugs Production Capacity (2016-2026) & (K MT)
Figure 21. Global Oncology/Cancer Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 22. Oncology/Cancer Drugs Market Drivers
Figure 23. Oncology/Cancer Drugs Market Restraints
Figure 24. Oncology/Cancer Drugs Market Trends
Figure 25. Global Oncology/Cancer Drugs Sales Market Share by Manufacturer in 2020
Figure 26. Global Oncology/Cancer Drugs Revenue Market Share by Manufacturer in 2020
Figure 27. Oncology/Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. Top 3 Oncology/Cancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 29. Top 6 Oncology/Cancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 30. Global Oncology/Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 31. Global Oncology/Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 32. North America Oncology/Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 33. Europe Oncology/Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 34. Asia-Pacific Oncology/Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 35. South America Oncology/Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 36. Middle East & Africa Oncology/Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 37. Global Oncology/Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 38. Global Oncology/Cancer Drugs Revenue Market Share by Type (2016-2026)
Figure 39. Global Oncology/Cancer Drugs Price by Type (2016-2026) & (USD/MT)
Figure 40. Global Oncology/Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 41. Global Oncology/Cancer Drugs Revenue Market Share by Application (2016-2026)
Figure 42. Global Oncology/Cancer Drugs Price by Application (2016-2026) & (USD/MT)
Figure 43. North America Oncology/Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 44. North America Oncology/Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 45. North America Oncology/Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 46. North America Oncology/Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 47. United States Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Oncology/Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 51. Europe Oncology/Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 52. Europe Oncology/Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 53. Europe Oncology/Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 54. Germany Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Oncology/Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Oncology/Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Oncology/Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Oncology/Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 63. China Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Korea Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Oncology/Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 70. South America Oncology/Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 71. South America Oncology/Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 72. South America Oncology/Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East & Africa Oncology/Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Oncology/Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 77. Middle East & Africa Oncology/Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Oncology/Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 79. Turkey Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Egypt Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Saudi Arabia Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. South Africa Oncology/Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
胃腸がんの薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected …- 世界の精巣がん治療薬市場 2021：企業別、地域別、種類・用途別 The Testicular Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の卵巣がん治療薬市場 2021：企業別、地域別、種類・用途別 The Ovarian Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 肝臓がん用薬の世界市場2018-2025 Kidney/Renal Cancer Drugs are used to cure kidney cancers.The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boo…
- 肝臓癌治療薬の世界市場2018-2025 Liver cancer resists most chemo drugs. The liver cancer drugs that have been most effective as systemic chemo in liver cancer are doxorubicin (Adriamycin), 5-fluorouracil, and cisplatin. But even these drugs shrink only a small portion of tumors, and the responses often do not last long.In 2018, the…